IGBP1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
B cell	25 studies	27% ± 8%	Explore
CD4-positive, alpha-beta T cell	24 studies	25% ± 8%	Explore
natural killer cell	22 studies	21% ± 6%	Explore
regulatory T cell	19 studies	29% ± 6%	Explore
CD8-positive, alpha-beta T cell	18 studies	24% ± 7%	Explore
fibroblast	18 studies	24% ± 8%	Explore
T cell	17 studies	21% ± 5%	Explore
smooth muscle cell	16 studies	22% ± 5%	Explore
memory B cell	16 studies	23% ± 4%	Explore
naive B cell	16 studies	22% ± 5%	Explore
classical monocyte	15 studies	27% ± 11%	Explore
basal cell	14 studies	27% ± 12%	Explore
conventional dendritic cell	13 studies	30% ± 15%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	13 studies	27% ± 7%	Explore
non-classical monocyte	12 studies	30% ± 14%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	11 studies	26% ± 7%	Explore
connective tissue cell	11 studies	24% ± 6%	Explore
epithelial cell	11 studies	36% ± 20%	Explore
gamma-delta T cell	11 studies	26% ± 14%	Explore
pericyte	10 studies	25% ± 5%	Explore
endothelial cell	10 studies	25% ± 10%	Explore
ciliated cell	10 studies	25% ± 10%	Explore
CD16-negative, CD56-bright natural killer cell, human	9 studies	23% ± 4%	Explore
mature NK T cell	9 studies	19% ± 2%	Explore
myofibroblast cell	9 studies	25% ± 4%	Explore
monocyte	9 studies	20% ± 5%	Explore
mast cell	8 studies	21% ± 7%	Explore
plasma cell	8 studies	26% ± 10%	Explore
CD4-positive, alpha-beta memory T cell	8 studies	26% ± 7%	Explore
CD16-positive, CD56-dim natural killer cell, human	8 studies	22% ± 4%	Explore
mucosal invariant T cell	8 studies	20% ± 3%	Explore
endothelial cell of vascular tree	8 studies	19% ± 3%	Explore
goblet cell	7 studies	29% ± 12%	Explore
dendritic cell	7 studies	32% ± 21%	Explore
T follicular helper cell	7 studies	24% ± 2%	Explore
plasmacytoid dendritic cell	7 studies	24% ± 7%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	20% ± 4%	Explore
enterocyte	6 studies	27% ± 6%	Explore
abnormal cell	6 studies	28% ± 10%	Explore
precursor B cell	6 studies	29% ± 9%	Explore
macrophage	6 studies	23% ± 7%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	28% ± 12%	Explore
effector memory CD8-positive, alpha-beta T cell	5 studies	28% ± 5%	Explore
progenitor cell	5 studies	29% ± 7%	Explore
enteroendocrine cell	5 studies	26% ± 9%	Explore
intestinal crypt stem cell	5 studies	27% ± 6%	Explore
mesothelial cell	5 studies	35% ± 15%	Explore
hematopoietic stem cell	5 studies	29% ± 9%	Explore
neuron	5 studies	33% ± 16%	Explore
endothelial cell of lymphatic vessel	5 studies	22% ± 7%	Explore
secretory cell	5 studies	26% ± 6%	Explore
leukocyte	4 studies	22% ± 3%	Explore
exhausted T cell	4 studies	35% ± 17%	Explore
plasmablast	4 studies	37% ± 20%	Explore
pro-B cell	4 studies	30% ± 4%	Explore
immature B cell	4 studies	24% ± 1%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	35% ± 6%	Explore
innate lymphoid cell	4 studies	20% ± 2%	Explore
astrocyte	4 studies	19% ± 3%	Explore
glutamatergic neuron	4 studies	35% ± 12%	Explore
oligodendrocyte precursor cell	4 studies	22% ± 6%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	33% ± 10%	Explore
oligodendrocyte	4 studies	17% ± 1%	Explore
hematopoietic precursor cell	3 studies	45% ± 15%	Explore
mononuclear phagocyte	3 studies	31% ± 11%	Explore
epithelial cell of proximal tubule	3 studies	25% ± 6%	Explore
neural crest cell	3 studies	20% ± 4%	Explore
myeloid cell	3 studies	27% ± 9%	Explore
brush cell	3 studies	25% ± 11%	Explore
club cell	3 studies	24% ± 5%	Explore
germinal center B cell	3 studies	32% ± 6%	Explore
GABAergic neuron	3 studies	31% ± 5%	Explore
group 3 innate lymphoid cell	3 studies	29% ± 12%	Explore
T-helper 1 cell	3 studies	23% ± 6%	Explore
central memory CD4-positive, alpha-beta T cell	3 studies	25% ± 7%	Explore
double negative thymocyte	3 studies	36% ± 18%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	20% ± 4%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	13 studies	29% ± 8%	Explore
lung	9 studies	25% ± 6%	Explore
intestine	8 studies	26% ± 10%	Explore
kidney	5 studies	21% ± 3%	Explore
uterus	4 studies	28% ± 15%	Explore
lymph node	4 studies	24% ± 1%	Explore
brain	4 studies	28% ± 7%	Explore
liver	4 studies	24% ± 12%	Explore
bone marrow	3 studies	19% ± 2%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
esophagus	100%	2969.11	1445 / 1445	100%	76.57	183 / 183
ovary	100%	6682.28	180 / 180	100%	91.76	430 / 430
pancreas	100%	4701.44	328 / 328	100%	100.64	178 / 178
prostate	100%	3177.57	245 / 245	100%	134.12	502 / 502
skin	100%	4071.67	1809 / 1809	100%	94.36	472 / 472
thymus	100%	3741.96	653 / 653	100%	190.71	604 / 605
intestine	100%	4031.08	966 / 966	100%	137.98	526 / 527
bladder	100%	3723.62	21 / 21	100%	107.52	503 / 504
uterus	100%	4136.99	170 / 170	100%	90.78	458 / 459
kidney	100%	3133.63	89 / 89	100%	114.33	899 / 901
lung	100%	2731.91	576 / 578	100%	87.07	1155 / 1155
stomach	100%	3797.84	359 / 359	100%	118.42	285 / 286
breast	100%	3913.36	459 / 459	100%	100.26	1114 / 1118
brain	99%	2239.53	2621 / 2642	100%	93.54	705 / 705
adrenal gland	100%	2967.95	258 / 258	98%	76.59	226 / 230
liver	81%	701.41	182 / 226	97%	51.15	394 / 406
adipose	100%	3894.78	1204 / 1204	0%	0	0 / 0
blood vessel	100%	3529.24	1335 / 1335	0%	0	0 / 0
eye	0%	0	0 / 0	100%	176.56	80 / 80
lymph node	0%	0	0 / 0	100%	177.29	29 / 29
muscle	100%	4754.35	803 / 803	0%	0	0 / 0
spleen	100%	2898.89	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	80.21	45 / 45
ureter	0%	0	0 / 0	100%	58.95	1 / 1
peripheral blood	98%	2841.07	909 / 929	0%	0	0 / 0
heart	96%	2386.02	830 / 861	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0

III. Associated gene sets

GO_0043154	Biological process	negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO_0007165	Biological process	signal transduction
GO_0032873	Biological process	negative regulation of stress-activated MAPK cascade
GO_0035303	Biological process	regulation of dephosphorylation
GO_0070555	Biological process	response to interleukin-1
GO_0000122	Biological process	negative regulation of transcription by RNA polymerase II
GO_0042113	Biological process	B cell activation
GO_0034612	Biological process	response to tumor necrosis factor
GO_0060632	Biological process	regulation of microtubule-based movement
GO_0005829	Cellular component	cytosol
GO_0005737	Cellular component	cytoplasm
GO_0051721	Molecular function	protein phosphatase 2A binding
GO_0019888	Molecular function	protein phosphatase regulator activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	IGBP1
Protein name	Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16)
Synonyms	IBP1
Description	FUNCTION: Associated to surface IgM-receptor; may be involved in signal transduction. Involved in regulation of the catalytic activity of the phosphatases PP2A, PP4 and PP6 by protecting their partially folded catalytic subunits from degradative polyubiquitination until they associate with regulatory subunits. .
Accessions	ENST00000356413.5 P78318 ENST00000342206.10

IGBP1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review